NCT02748733

Brief Summary

The purpose of this study is to validate the concept of adapted automated PD a modified Peritoneal Equilibration Test (PET), will be performed in children on chronic PD. Instead of a single 4 hour standard dwell, two double mini PET using the same type and total volume of dialysate and the same total dwell time (150min) will be performed in randomised sequence. An double mini test consists of two identical dwells, reflecting routine PD, the other one of a short small dwell followed by a long, large dwell as suggested from adapted PD regimes successfully applied in adult PD patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

April 13, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 22, 2016

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

May 8, 2018

Status Verified

May 1, 2018

Enrollment Period

1.6 years

First QC Date

April 13, 2016

Last Update Submit

May 2, 2018

Conditions

Keywords

Adapted APDDialytic Sodium RemovalUltrafiltrationClearance rateIntraperitoneal pressure

Outcome Measures

Primary Outcomes (1)

  • Dialytic sodium removal, i.e. the amount of sodium (mmol) per double mini PET (via ultrafiltration and diffusive sodium transport)

    two double mini PET each comprising 150 min of dialysis

    2 x 150 min with one 1 hour inbetween each PET

Secondary Outcomes (1)

  • dialytic water and solute removal, i.e. ultrafiltrate per double mini PET (ml/gram intraperitoneal glucose exposure), phosphate removal per dmPET (mmol); Kt/V, clearance of creatinine (ml/min*1.73m²), intraperitoneal pressure (cm water)

    2 x 150 min with one 1 hour inbetween each PET

Study Arms (2)

Adapted double mini PET

ACTIVE COMPARATOR

PET = Peritoneal Equilibration Test, a test routinely performed to measure peritoneal transport rates of solutes and water in peritoneal dialysis patients. To this end the routinely administered dialysis fluid is infused into the peritoneal cavity. The test will be modified (adapted): A short, small cycle (0.6 mL/m² BSA, 30 min) followed by a long, large cycle (1.4 mL/m², 120 min) will be performed in each patient and compared to a standard double mini PET.

Other: Adapted double mini PET

Standard double mini PET

PLACEBO COMPARATOR

The Standard double mini PET consists of two identical cycles (fill volume 1 L/m², 75 min of dwell time)

Other: Standard double mini PET

Interventions

The modified double mini PET mimics the treatment of adapted PD and thus allows its validation

Also known as: Peritoneal Equilibration Test (PET), Peritoneal dialysis
Adapted double mini PET

The standard double mini PET reflects the routine PD treatment in children and is used for standardized comparison

Also known as: Peritoneal Equilibration Test (PET), Peritoneal dialysis
Standard double mini PET

Eligibility Criteria

Age5 Years - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • PD patients 5-21 years of age
  • Stable PD
  • Last peritonitis \> 4 weeks ago

You may not qualify if:

  • Polyuria and dehydrated patients (as to the clinical status RR, HR and BCM) not allowing for more than 1.5% glucose content of PD fluid
  • Hypoalbuminemia (serum albumin \< 25g/l)
  • Relevant changes in dialysis regime and diet the three days preceding the study
  • Hb \< 9 mg/dl
  • Pregnancy
  • History of repeated hernia or PD fluid leakage
  • Intolerability of intraperitoneal pressure of up to 18 cm H2O at 1400ml/m²
  • BSA in supine position (e.g. due to organomegaly)
  • Any underlying diseases affecting the peritoneal membrane transport function (such as previous surgery with subsequent adhesions and fluid trapping, chronic bowl disease)
  • Heart insufficiency
  • Patients with catheter dysfunction, i.e. outflow problems (assessed by cycler alarms during the last 2 weeks)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Pediatric and Adolescent Medicine

Heidelberg, Baden-Wurttemberg, 69120, Germany

Location

Related Publications (3)

  • Fischbach M, Schmitt CP, Shroff R, Zaloszyc A, Warady BA. Increasing sodium removal on peritoneal dialysis: applying dialysis mechanics to the peritoneal dialysis prescription. Kidney Int. 2016 Apr;89(4):761-6. doi: 10.1016/j.kint.2015.12.032. Epub 2016 Jan 21.

  • Fischbach M, Zaloszyc A, Schaefer B, Schmitt CP. Optimizing peritoneal dialysis prescription for volume control: the importance of varying dwell time and dwell volume. Pediatr Nephrol. 2014 Aug;29(8):1321-7. doi: 10.1007/s00467-013-2573-x. Epub 2013 Aug 2.

  • Fischbach M, Issad B, Dubois V, Taamma R. The beneficial influence on the effectiveness of automated peritoneal dialysis of varying the dwell time (short/long) and fill volume (small/large): a randomized controlled trial. Perit Dial Int. 2011 Jul-Aug;31(4):450-8. doi: 10.3747/pdi.2010.00146. Epub 2011 Mar 31.

MeSH Terms

Interventions

Peritoneal Dialysis

Intervention Hierarchy (Ancestors)

Renal DialysisRenal Replacement TherapyTherapeuticsSorption Detoxification

Study Officials

  • Claus P Schmitt, MD

    Center for Pediatric and Adolescent Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. med.

Study Record Dates

First Submitted

April 13, 2016

First Posted

April 22, 2016

Study Start

April 1, 2016

Primary Completion

October 31, 2017

Study Completion

January 1, 2018

Last Updated

May 8, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations